NCT00031395View on ClinicalTrials.gov

Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

September 30, 1999

Study Completion Date

June 30, 2007

Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG

clonidine

Clonidine is FDA-approved for the treatment of hypertension in adults.

DRUG

methylphenidate

MPH is FDA-approved for the treatment of ADHD symptoms in children.

OTHER

placebo

an inactive substance

Trial Locations (4)

14214

SUNY Buffalo, Center For Children & Families, Buffalo

14642

University of Rochester, Department of Neurology, Rochester

45229

Children's Hospital Medical Center, Cincinnati

Unknown

Western Psychiatric Institute and Clinic, Pittsburgh

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Cincinnati

OTHER

NCT00031395 - Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children | Biotech Hunter | Biotech Hunter